Compound Detail
CHEMBL4753335
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4753335 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | GKQRUHQWGMCIKL-UHFFFAOYSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
411.5
MW (Da)
6.23
ALogP
3
HBA
3
HBD
79.5
PSA (Ų)
0.36
QED
1
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 6.59
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| HepG2 CHEMBL395 | IC50 | 6.59 | 6.59 | 257.8 | 1 |
| MCF7 CHEMBL387 | IC50 | 6.02 | 6.02 | 953.3 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 5.85 | 5.85 | 1413.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HepG2 | IC50 | = | 257.8 | nM | 6.59 | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability i... | 33002846 |
| MCF7 | IC50 | = | 953.3 | nM | 6.02 | Cytotoxicity against human MCF7 cells assessed as reduction in cell viability in... | 33002846 |
| MDA-MB-231 | IC50 | = | 1413.0 | nM | 5.85 | Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viabil... | 33002846 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 33002846 | 10.1016/j.ejmech.2020.112851 | MDA-MB-231 | 6 |
| 33002846 | 10.1016/j.ejmech.2020.112851 | MCF7 | 2 |
| 33002846 | 10.1016/j.ejmech.2020.112851 | HepG2 | 2 |
| 33002846 | 10.1016/j.ejmech.2020.112851 | Chorioallantoic membrane | 1 |
Data from ChEMBL 36 via Core Engine